All People News articles – Page 5
-
NewsResearchers test two treatments to protect against deadly cattle disease
As cases of a deadly cattle disease rise in Arkansas, researchers are testing two treatments they hope will help ranchers protect their herds. The disease is bovine theileriosis and is caused by the parasite Theileria orientalis Ikeda, carried primarily by the invasive Asian longhorned tick.
-
NewsQ&A: Meet Letters in Applied Microbiology Junior Reviewer Md. Ekramul Karim
We caught up with Md Ekramul Karim, a Ph.D. candidate at the University of Houston, who is one of the newest Junior Reviewers with Letters in Applied Microbiology.
-
NewsAll-new lab in Kenya fills critical gap in wildlife health
Conservation stakeholders gathered to celebrate the official opening of the Laboratory in Northern Kenya (LiNK), an all-new veterinary diagnostic lab designed to fill a critical need for accessible diagnostic infrastructure in the remote region.
-
NewsAccelerating chikungunya vaccine development in Africa: Launch of the ACT-CHIK Project
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.
-
NewsEurope’s crops under threat: €6 million project launches to tackle rising plant pest crisis
The University of Warwick leads a European consortium to build the first platform capable of coordinating Europe’s response to devastating agricultural and forest pest invasions. The project will give plant health authorities the ability to model and optimise pest control strategies across the entire agri-value chain.
-
NewsResearch team awarded NIH grant to study early immune determinants of human tuberculosis infection
A research team was awarded a 5-year, $3.8 million grant to study early immune responses in the lung and how they influence tuberculosis infection outcomes. The program focuses on how lung immune cells called macrophages influence the earliest stages of tuberculosis infection.
-
NewsDentistry researchers testing oral bacteria transplants to cure bad breath
To rebalance the oral microbiome and cure chronic halitosis, researchers are embarking on a first-of-its-kind experiment. These clinical trials transplant bacteria and other microbes from healthy donors into patients with halitosis. If successful, the healthy microbiota will crowd out the bad and patients’ bad breath will improve.
-
NewsProfessor Kaneko’s sake and wine earn honors at French Japanese Sake Competition for second consecutive year
At “Kura Master,” a Japanese sake competition held in France for French consumers since 2017, “Aldebaran,” a wine produced from grapes grown in the city of Ibara, in Okayama Prefecture, and supervised by Professor Akihiro Kaneko, won a Gold Award in the Muscat Bailey A category.
-
NewsData from patients hospitalised with COVID-19 made available to the scientific community
The DIVINE study database has been published. The cohort includes clinical information from 5,813 patients hospitalised with COVID-19 during four waves of the pandemic, between March 2020 and August 2021, across five hospitals in the southern metropolitan area of Barcelona.
-
NewsResearcher studying probiotics to fight acid reflux and esophageal cancer
Patients with acid reflux, which occurs when stomach acid pushes up into the esophagus, know the symptoms all too well: heartburn, belching, chest pain and trouble swallowing. Acid reflux also increases the risk of esophageal cancer, but researchers are investigating how a simple probiotic could treat and prevent both conditions.
-
NewsThe future of phage therapy will be decided by more than science alone
As antimicrobial resistance accelerates worldwide, leading experts gather in Valencia to address the scientific, regulatory, manufacturing and clinical challenges that will determine whether phage therapy becomes a routine healthcare solution.
-
News CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates
The Coalition for Epidemic Preparedness Innovations (CEPI) will urgently accelerate development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda.
-
NewsGladstone launches Center for PhAIge Therapy to harness AI in the fight against drug-resistant infections
Gladstone Institutes has received funding to establish the Center for PhAIge Therapy, a research center that will develop new phage-based treatments for antibiotic-resistant bacterial infections. The five-year grant makes Gladstone one of three institutions across the country selected to lead this coordinated effort.
-
NewsEU project aims to make climate-neutral plastics and cosmetics using bacteria
A European research team is aiming to revolutionize the chemical industry: as part of the CarboNcare project, scientists are developing bacteria that can produce important chemical base materials from sustainable methanol – thereby replacing fossil resources.
-
NewsAsian scientists unveil 10-year roadmap for building synthetic cells
Scientists from six Asian countries have launched an ambitious 10-year effort to build synthetic cells from non-living molecules, marking the region’s first coordinated push to create an artificial single-celled biological system.
-
NewsPan-European One Health Network established to bolster infectious disease response
iiCON: the Infection Innovation Consortium has successfully secured funding from COST to establish a unique pan-European COST Action network with over 70 collaborators from 21 countries and international organisations to harmonise the European response to infectious disease threats.
-
NewsBehind the diagnosis: How laboratory testing guided a complex histoplasmosis case
A diagnosis of histoplasmosis forced a teenager with juvenile arthritis onto an uncertain path, one defined by months of treatment, recovery, and a long-term course of antifungal therapy expected to last up to three years. Histoplasma capsulatum, a dimorphic fungus that causes histoplasmosis, found its way into her lungs.
-
NewsHealth researchers call for support to develop pandemic prevention
The Vanderbilt Center for Antibody Therapeutics has received large-scale government grants and contracts to fund the discovery of human antiviral antibodies. The problem is the next step — finding corporate partners to develop the antibodies through human testing.
-
NewsSoil scientist awarded $1.6 million NSF grant to study ‘living skin’ of arid ecosystems
A soil scientist has received a $1.6 million, five-year grant from the U.S. National Science Foundation (NSF) to fund her team’s study of how increasing temperature fluctuations impact the biocrust microbiome — the complex, thin-layer microbe community that stabilizes soil, fixes nitrogen and drives nutrient cycling in drylands.
-
NewsVote now! Record number of candidates vie in AMI Trustee election
It’s time to have your say! Applied Microbiology International (AMI) is calling on all members to vote in the Trustee election after receiving record nominations.